Searched for
IPCA LABS MANUFACTURING
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Ipca Labs expects its US generics sales to touch $200 million soonIpca Laboratories, after resolving regulatory hurdles and integrating Unichem, is set to re-enter the US generics market aiming for $200 mi...
- Makers of potential Covid drugs, testing cos may draw investorsCadila has 32 per cent market share in API hydroxychloroquine in the US.
- Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drugIPCA has a market share of nearly 70% of these drugs, as it is one of the largest suppliers of the active pharmaceutical ingredient of thes...
- Cadila, Torrent, Ipca Labs surge as malaria drug found effective against Covid-19Trump touted that generic malaria drug hydroxychloroquine has been used with some success in treating Covid-19.
- US health regulator finds Silvassa unit non-compliant with CGMP: Ipca LabsThe company said that since this manufacturing facility is already under USFDA import alert and presently not doing any US business, this w...
- In beaten down Pharma Inc, Aurobindo still offers hopeIn the last one year, the ET Pharma Index has fallen by 21 per cent.
- 2 stocks that will help you make money: Gaurang Shah, VP, Geojit BNP ParibasThe entire pharma pack in the recent time has shown some turnaround and buying interest and given we are sure that downside if any is quite...
- Ipca Labs gets warning letter from USFDA for 3 plantsIpca Laboratories has received warning letter from the US health regulator for three facilities on which the regulator had earlier imposed ...
- Should investors buy Ipca Labs after sharp fall?As Ipca falls over 12% following import alerts for its manufacturing units, analysts feel it will take long time for the co to resolve issu...
- US FDA issues import alert to 2 plants of IPCA LaboratoriesThe U.S. regulator had in January banned imports from a separate central Indian manufacturing plant of Ipca, citing violations of standard ...
- IPCA Labs plunges over 11% on USFDA alertIPCA Laboratories plunged over 11%in trade following reports that it has received US FDA import alert at two manufacturing facilities.
- Ipca Labs stock tanks 8% on FDA import alert for Ratlam plantShares of Ipca Labs ended with a steep loss of over 8 per cent today after the US health regulator issued import alert on drugs produced at...
- Ipca Labs steps up R&D expenditure to Rs 100.74 crorePharma firm Ipca Laboratories Ltd said it has stepped up its R&D expenditure to Rs 100.74 crore in FY'13 from Rs 77.96 crore in the previou...
- Ipca Laboratories tanks on delay in production at Indore SEZIPCA Labs slipped over 10 pc in early trade after the company highlighted a few manufacturing issues at Indore SEZ to USFDA.
- Ipca Labs manufacturing unit gets UK health regulator's nodIpca Laboratories today said its formulations manufacturing unit at a Special Economic Zone in Indore has received the UK health regulator'...
- Ipca & Makers hike stake in Mangalam Drugs to 14%Mumbai-based mid-size pharma company Ipca Laboratories along with Makers Laboratories has picked up additional stake in bulk drugs and chem...
- Ipca Labs picks up 10% stake in Mangalam DrugsMumbai-Based Ipca Labs has picked up a little over 10% equity in Mangalam Drugs and Organics, a small-sized bulk drugs and chemicals compan...
Load More
